Capital
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement ...
MariMed Inc. Secures $58.7 Million Loan from Needham Bank to Bolster Operations and Reduce Debt
LOS ANGELES- MariMed Inc. a player in the cannabis industry, has recently finalized a substantial financial deal with Needham Bank, a community bank based in Massachusetts. ...
AYR Wellness Financial Performance in Q3 2023
NEW YORK– AYR Wellness Inc. U.S. multi-state cannabis operator, has disclosed its financial results for the third quarter ending September 30, 2023. The company reported a ...
Florida High Court Favoring Voter Decision on Cannabis Legalization
NEW YORK– In a significant development for cannabis legalization advocates in Florida, the state's Supreme Court appears inclined to permit a proposal for adult-use cannabis legalization ...
Cresco Labs Delivers Q3 2023 Results, Execution of Core Market Strategy
NEW YORK– Cresco Labs Inc., a player in the cannabis industry, has unveiled its third-quarter financial and operating results for the period ending September 30, 2023. ...
Cybin Inc. Secures $30 Million in Funding, Strengthening Pathway for Psychedelic-Based Mental Health Treatments
LOS ANGELES— Cybin Inc., a prominent clinical-stage biopharmaceutical company, has successfully closed its substantial underwritten offering, amassing US$30 million to propel its mission of transforming mental ...
Clearmind Medicine Partners with Johns Hopkins and Yale for Pioneering Alcohol Use Disorder Clinical Trial
Tel Aviv— Clearmind Medicine Inc., a trailblazer in psychedelic drug development, has announced a significant milestone in its journey to address Alcohol Use Disorder (AUD). The ...
Glass House Brands Inc. Record in Q3 2023
LOS ANGELES- Glass House Brands Inc., a player in the cannabis industry, announced its financial achievements for the third quarter ending September 30, 2023, marking a ...
